Rhythm Pharmaceuticals (RYTM) Deferred Taxes (2021)

Rhythm Pharmaceuticals (RYTM) posted quarterly Deferred Taxes of -$9.0 million for Q3 2021, down 79.11% quarter-over-quarter from -$5.0 million in Q2 2021.

Rhythm Pharmaceuticals (RYTM) Deferred Taxes (2021) Analysis & Trends

Rhythm Pharmaceuticals (RYTM) has reported Deferred Taxes for 1 consecutive years, with -$9.0 million the latest figure, recorded in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -137,876.64
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.66 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Rhythm Pharmaceuticals 7.95 Bn 7.62 Bn 62.32 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 -9.00 Mn
Jun 30, 2021 -5.02 Mn
Mar 31, 2021 22.01 Mn